It has been reported that IL-2 and IL-10 and their signaling pathways are elevated in the brain of AD patients (Strle et al., 2001; Gezen-Ak et al., 2013; Guillot-Sestier et al., 2015a). This evidence concerns the gene IL10 and Alzheimer disease.